Category: AmCham News
The Value of Confidentiality A recent court ruling raises the question of confidentiality in Norway’s public procurement processes. The Norwegian State procures goods and services in excess of NOK 600B per year. Most procurements are organized through competitive bids. The value of bid confidentiality thus becomes evident. Competition amongst bidders, for example on net price […]
Source: AmCham
Category: AmCham News
Today we proudly launch our Multinational Healthcare Investment in Norway: Fulfilling Potential report, assessing Norway’s ability to grow its engagement within a life-saving – and particularly competitive – global industry. We thank all industry leaders who have contributed with their first-hand insight and healthcare perspectives on Norway’s greatest existing barriers – and most promising recommendations […]
Source: AmCham
Category: AmCham News
AmCham Norway’s Healthcare Working Group – comprised of directors of the leading international pharmaceutical companies in the country – works to improve Norwegian patients’ access to the most effective, innovative, and timely treatments available. The working group contributes to a wide range of healthcare policy discussions, providing policymakers and relevant stakeholders with genuine industry information and insight. This position paper summarizes the group’s positions on healthcare innovation, market access, and the pursuit of enhanced collaboration with the public sector, positions that reflect the group’s unyielding commitment to improving patient outcomes and building an improved, more sustainable healthcare system in Norway.
Source: AmCham
Category: AmCham News
There are few things better than the excitement and passion of Arendalsuka, and AmCham made the trek down to southern Norway again this year to put on an exciting program of healthcare-related events featuring a diverse array of industry leaders and politicians.
Source: AmCham
Category: AmCham Norway
— AmCham ser ingen grunn til at det skal være ulikt for offentlige anskaffelser av legemidler i forhold til anskaffelser i andre sektorer, eller helsesektoren for øvrig, sa Katja Dahl Murphy, Myndighetskontakt i AmCham Norway, på høringen om konfidensielle legemiddelpriser i regi av Stortingets Helse- og omsorgskomite tidligere i dag (torsdag). — Konfidensialitet rundt enhetspriser […]
Source: AmCham